Product Description: Tezepelumab (anti-TSLP) is human monoclonal antibody (IgG2λ) that binds specifically to TSLP, blocking it from interacting with its heterodimeric receptor. Tezepelumab can be used for the research of severe, uncontrolled asthma[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Menzies-Gow A, et, al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N Engl J Med. 2021 May 13;384(19):1800-1809.
CAS Number: 1572943-04-4
Molecular Weight: N/A
Compound Purity: 98.64
Research Area: Inflammation/Immunology
Solubility: H2O
Target: Others